These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19806150)

  • 21. Comprehensive treatment of dactylitis in psoriatic arthritis.
    Rose S; Toloza S; Bautista-Molano W; Helliwell PS;
    J Rheumatol; 2014 Nov; 41(11):2295-300. PubMed ID: 25362714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the treatment of peripheral arthritis in psoriatic arthritis.
    Soriano ER; Rosa J
    Curr Rheumatol Rep; 2009 Aug; 11(4):270-7. PubMed ID: 19691930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress of biological agents on psoriatic arthritis.
    Li Y; Wang D; Wang Y; Shi G
    Curr Pharm Biotechnol; 2014; 15(6):525-34. PubMed ID: 25213361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic and therapeutic challenge of early psoriatic arthritis.
    Gisondi P; Tinazzi I; Del Giglio M; Girolomoni G
    Dermatology; 2010; 221 Suppl 1():6-14. PubMed ID: 20733310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of psoriatic arthritis.
    Balakrishnan C; Madnani N
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S18-24. PubMed ID: 23974691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on the diagnosis and management of psoriatic arthritis.
    Weger W
    G Ital Dermatol Venereol; 2011 Feb; 146(1):1-8. PubMed ID: 21317852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Tumor Necrosis Factor-α Blockers in Psoriatic Disease. Therapeutic Options in Psoriatic Arthritis.
    Addimanda O; Possemato N; Caruso A; Pipitone N; Salvarani C
    J Rheumatol Suppl; 2015 Nov; 93():73-8. PubMed ID: 26523063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment recommendations for psoriatic arthritis.
    Ritchlin CT; Kavanaugh A; Gladman DD; Mease PJ; Helliwell P; Boehncke WH; de Vlam K; Fiorentino D; Fitzgerald O; Gottlieb AB; McHugh NJ; Nash P; Qureshi AA; Soriano ER; Taylor WJ;
    Ann Rheum Dis; 2009 Sep; 68(9):1387-94. PubMed ID: 18952643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
    Haugeberg G; Michelsen B; Kavanaugh A
    RMD Open; 2020 May; 6(1):. PubMed ID: 32409518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnosis of early psoriatic arthritis.
    Altomare G; Capsoni F
    G Ital Dermatol Venereol; 2013 Oct; 148(5):501-4. PubMed ID: 24005143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis.
    Allard A; Antony A; Shaddick G; Jadon DR; Cavill C; Robinson G; Korendowych E; McHugh N; Tillett W
    Rheumatology (Oxford); 2019 Feb; 58(2):269-273. PubMed ID: 30247726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
    Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Treatment Concepts in Psoriatic Arthritis.
    Boyd T; Kavanaugh A
    Rheum Dis Clin North Am; 2015 Nov; 41(4):739-54. PubMed ID: 26476230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
    Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriatic arthritis: update on pathophysiology, assessment and management.
    Mease PJ
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i77-84. PubMed ID: 21339225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ustekinumab: The "New Kid on the Block" in the Treatment of Psoriatic Arthritis.
    Torres T; Faria R
    Drug Dev Res; 2015 Dec; 76(8):428-31. PubMed ID: 26372543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALIGN PsA: Advancing a Multidisciplinary Approach in PsA.
    Baum EW; Schwartzman S
    Semin Cutan Med Surg; 2018 Dec; 37(6S):S125-S134. PubMed ID: 30605493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis?
    Lubrano E; Soriano E; FitzGerald O
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S54-8. PubMed ID: 24129139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis.
    Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P
    J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.